echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Rheumatology: Predictive value of the adjusted global APS score for clinical recurrence in patients with antiphospholipid syndrome, a longitudinal study

    Rheumatology: Predictive value of the adjusted global APS score for clinical recurrence in patients with antiphospholipid syndrome, a longitudinal study

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    OBJECTIVE: To assess the effect of mean adjusted global APS total score (aGAPSS) on recurrence of clinical manifestations in patients with antiphospholipid syndrome (APS) in a retrospective longitudinal study


    Methods: The study included 200 patients with APS


    In patients taking vitamin K antagonists (VKA), the percentage of time spent in the therapeutic range (TTR) was calculated


    Results: The mean aGAPSS value of patients with clinical recurrence was higher than that of patients without recurrence [8.


    The mean aGAPSS value of patients with recurrent thrombosis was higher than that of patients with recurrent miscarriage [9.


    The mean aGAPSS value of patients with arterial thrombosis was higher than that of patients with venous thrombosis [10.


    In multivariate analysis, aGAPSS values ​​>13 were associated with the highest risk of recurrence [HR = 3.


    Conclusions: Data from this study support the role of regular (annual) monitoring of the aGAPSS score in predicting clinical relapse in patients with APS


    Source:

    Barilaro G, Esteves A, Della Rocca C, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.